Cmg financial emblem dominating the new england skyline

CMG Financial Expands Presence in New England Through Strategic Acquisition of Shamrock Home Loans’ Origination Team

California-based mortgage lender strengthens its position with a strategic acquisition

In a strategic move aimed at enhancing its presence in New England, CMG Financial, a prominent California-based mortgage lender, has integrated Shamrock Home Loans’ origination team. This acquisition marks a significant milestone for CMG Financial as it continues to expand its operations and strengthen its position in the mortgage lending industry.

A Strategic Integration for Enhanced Market Presence

Under the leadership of Kurt Noyce, Chief Growth Officer, and Rod Correia, President, Shamrock Home Loans’ origination team will join CMG Financial. This team of sales and support professionals will remain in their current locations and be branded as Shamrock, Powered by CMG Home Loans. The integration of Shamrock’s expertise and resources will further enhance CMG Financial’s capabilities in serving the New England market.

CMG Financial’s Growth Strategy in Action

This integration is not the first strategic move by CMG Financial. Earlier this year, the company acquired Homebridge Financial Services’ retail division, expanding its retail lending business footprint. CMG Financial’s commitment to growth and innovation has positioned it as a leading mortgage lender in the country.

CMG Financial’s Impressive Standing in the Industry

According to estimates from Inside Mortgage Finance (IMF), CMG Financial ranked as the 16th-largest mortgage lender in the United States in the first nine months of 2023, with a total volume of $16 billion. This represents a significant increase of 17.5% compared to the previous year. With 1,826 loan officers and 401 active branches as of November 21, CMG Financial continues to establish itself as a major player in the industry.

The Success Story of Shamrock’s Origination Team

Shamrock’s origination team has achieved remarkable success, originating approximately $300 million in loans so far this year, according to data from the mortgage platform Modex. With eight loan officers and 13 branches, Shamrock has established itself as a trusted provider of mortgage services.

The Synergy Behind the Integration

Rod Correia, President of Shamrock Home Loans, highlighted CMG Financial’s diverse product portfolio as a key factor in their decision to join forces. CMG Financial offers a wide range of financing options, including construction-to-perm, renovation financing, builder programs, and home equity lines of credit. This expansive portfolio aligns with Shamrock’s commitment to providing comprehensive solutions to its clients.

A Strategic Move for Expansion and Growth

The integration of Shamrock Home Loans’ origination team with CMG Financial signifies a strategic move to expand CMG Financial’s presence in New England. With its impressive industry standing, commitment to growth, and innovative product offerings, CMG Financial is well-positioned to serve the evolving needs of borrowers in the region. As the mortgage industry continues to evolve, CMG Financial remains dedicated to providing exceptional service and empowering individuals on their homeownership journey.

Explore CMG Financial’s Range of Financing Options Today

Ready to Take the Next Step in Your Mortgage Journey?

To learn more about CMG Financial’s diverse product portfolio and begin your mortgage journey, visit our website.

Start Your Homeownership Journey with CMG Financial

Explore Financing Options

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Precision Medicine Market: A Tailored Approach Revolutionizing Healthcare

With increasing governmental and private investments, the demand for precision medicine is expected to rise steadily. The commitment to addressing chronic conditions, coupled with strategic industry collaborations and advanced diagnostic tools, will sustain market growth.

U.S. Wearable Medical Devices Market: Growth Trends and Future Prospects

The U.S. wearable medical devices market, currently valued at an estimated $11.45 billion in 2023, is set to experience an astronomical rise to approximately $112.67 billion by 2033.

By |December 3, 2024|Categories: Article, Healthcare, Technology|Tags: |0 Comments

The Future of Real Estate Market: What Lies Ahead?

The real estate market is on the brink of transformation, captivating the attention of buyers, sellers, investors, and industry professionals. As we look toward the end of 2024, experts predict a shift in the landscape, particularly with home prices expected to decline due to increased inventory levels.

By |December 3, 2024|Categories: Article, Market Trends, Real Estate|Tags: , |0 Comments

Bridging the Healthcare Gap in Rural Areas with Telehealth

According to the World Health Organization (WHO), nearly two billion people in rural and remote areas worldwide lack access to essential healthcare solutions. This staggering statistic highlights a critical issue: the digital divide that limits telehealth services, primarily due to inadequate broadband access.

By |December 2, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Navigating Ethical Challenges: AI in Healthcare

As AI becomes a staple in medical practice, it carries the risk of reinforcing existing biases entrenched in historical data. These biases can lead to skewed outcomes, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic groups.

By |December 2, 2024|Categories: Article, Ethics, Healthcare|Tags: , |0 Comments

New SCLC Biomarkers Enable Advances in Precision Medicine Approaches

A groundbreaking study published in Volume 15 of Oncotarget on October 11, 2024, titled 'Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC' showcases pivotal advancements in the fight against small cell lung cancer (SCLC).

By |December 2, 2024|Categories: Article, Cancer Treatment, Medical Research|Tags: , |0 Comments